美國居民不適用 XM 服務。
S
S

Stryker

交易方向

交易者脈動

技術摘要

小時

財經新聞

Stryker Corp <SYK.N> expected to post earnings of $2.79 a share - Earnings Preview

Stryker Corp expected to post earnings of $2.79 a share - Earnings Preview Stryker Corp SYK.N , SYK is expected to show a rise in quarterly revenue when it reports results on July 30 for the period ending June 30 2024 The Portage Michigan-based company is expected to report a 8.2% increase in revenue to $5.406 billion from $5 billion a year ago, according to the mean estimate from 24 analysts, based on LSEG data.
S

Some medical device makers rise, while others tip lower after J&J results

BUZZ-Some medical device makers rise, while others tip lower after J&J results ** Some medical device manufacturers rise after Johnson & Johnson's JNJ.N results, while others fall ** Zimmer Biomet ZBH.N rise 2.9% to $110.58, Medtronic MDT.N gain 2.45% to $80.01, Abbott ABT.N rise 2.10% to $104.90, Stryker SYK.N up 1.04% at $336.90 ** Shares of Intu
A
C
S
Z

J&J beats Wall St estimates on strong drug sales ahead of Stelara competition

CORRECTED-UPDATE 3-J&J beats Wall St estimates on strong drug sales ahead of Stelara competition Corrects paragraph 4 as J&J CFO did not suggest pending Stelara insurance contracts would be 'favorable' By Patrick Wingrove and Bhanvi Satija July 17 (Reuters) - Johnson & Johnson JNJ.N beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment Darzalex and blockbuster psoriasis drug Stelara .
A
S

Stryker Completes Acquisition Of Artelon

BRIEF-Stryker Completes Acquisition Of Artelon July 15 (Reuters) - Stryker Corp SYK.N : STRYKER COMPLETES ACQUISITION OF ARTELON, INC. Source text for Eikon: ID:nBw2Q55RHa Further company coverage: SYK.N
S

Smith & Nephew faces long and painful activist fix

BREAKINGVIEWS-Smith & Nephew faces long and painful activist fix The author is a Reuters Breakingviews columnist. The opinions expressed are her own. By Aimee Donnellan LONDON, July 4 (Reuters Breakingviews) - Smith & Nephew SN.L should prepare for a long and painful activist treatment. On Thursday, Swedish investor Cevian Capital announced it had taken a 5% stake in the $11 billion UK-listed maker of hip joints and wound care kit.
U
S

細節

熱門資產

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明